Fig. 1

Schematic flowchart of the trial. PDAC, pancreatic ductal adenocarcinoma; S1-PTX, intravenous and intraperitoneal paclitaxel with S-1; GnP, gemcitabine plus nanoparticle albumin-bound (nab)-paclitaxel
Schematic flowchart of the trial. PDAC, pancreatic ductal adenocarcinoma; S1-PTX, intravenous and intraperitoneal paclitaxel with S-1; GnP, gemcitabine plus nanoparticle albumin-bound (nab)-paclitaxel